Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease

Joseph Jacob, Catherine M. Owens, Alan S. Brody, Thomas Semple, Tom A. Watson, Alistair Calder, Pilar Garcia-Peña, Paolo Toma, Anand Devaraj, Henry Walton, Antonio Moreno-Galdó, Paul Aurora, Alexandra Rice, Timothy J. Vece, Steve Cunningham, Andre Altmann, Athol U. Wells, Andrew G. Nicholson, Andrew Bush
ERJ Open Research 2019 5: 00100-2019; DOI: 10.1183/23120541.00100-2019
Joseph Jacob
1Dept of Respiratory Medicine, University College London, London, UK
2Centre for Medical Image Computing, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph Jacob
  • For correspondence: j.jacob@ucl.ac.uk
Catherine M. Owens
3Dept of Radiology, Great Ormond Street Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan S. Brody
4Dept of Radiology, University of Cincinnati College of Medicine, and Cincinnati Children's Hospital, Cincinnati, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Semple
5Dept of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Semple
Tom A. Watson
3Dept of Radiology, Great Ormond Street Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alistair Calder
3Dept of Radiology, Great Ormond Street Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pilar Garcia-Peña
6Dept of Pediatric Radiology, University Hospital Vall d'Hebron, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Toma
7Dept of Radiology, Ospedale Pediatrico Bambino Gesù, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paolo Toma
Anand Devaraj
5Dept of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Walton
8Dept of Radiology, Royal Free London NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Moreno-Galdó
9Dept of Paediatric Respiratory Medicine, University Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBERER, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Aurora
10Dept of Paediatric Respiratory Medicine, Great Ormond Street Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Rice
11Dept of Hisopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy J. Vece
12Dept of Pediatrics, Division of Pediatric Pulmonology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Cunningham
13Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Altmann
2Centre for Medical Image Computing, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andre Altmann
Athol U. Wells
14Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew G. Nicholson
11Dept of Hisopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Bush
15Depts of Paediatrics and Paediatric Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Making chILD diagnoses on CT is poorly reproducible, even amongst sub-specialists. CT might best improve diagnostic confidence in a multidisciplinary team setting when augmented with clinical, functional and haematological results. http://bit.ly/327jRCw

To the Editor:

Interstitial lung diseases (ILDs) that present in childhood (chILD) are seen far less frequently than ILDs presenting in adults which themselves constitute rare disorders [1]. Histopathological [2, 3] and imaging [4] characterisation of chILD disease subtypes therefore lags behind adult ILDs. The field has also been constrained by comparisons with disease morphology in adults, despite the developmental differences in terms of growth and healing in the paediatric lung, which may alter disease patterns and distributions. The American Thoracic Society [5] and European [1] chILD management guidelines both specify a pivotal role for computed tomography (CT) imaging in the work-up of chILD patients to: 1) determine whether a chILD is present or not; and 2) where possible, to make a specific diagnosis of the underlying cause. For the second aim to be achieved, diagnostic reviews need to be reproducible between experts. Our study uniquely examined agreement between observers of varying experience in the CT evaluation of chILD to inform whether the current status of CT imaging and knowledge can be diagnostic of specific chILDs. We hypothesised that observer agreement for chILD groups and diagnoses would be limited. The study was not designed to relate CT agreement to final diagnosis. As a secondary analysis, we examined how CT interpretation differed between observers in children under and over 2 years of age.

84 patients (<2 years, n=35) from 13 countries, referred to the Royal Brompton Hospital paediatric ILD unit from 1999 to 2014 were re-evaluated by 10 observers: three chILD sub-specialist radiologists with >25 years' experience (C.M. Owens, P. Garcia-Peña, A.S. Brody); four chILD pulmonologists with >20 years' experience (S. Cunningham, T.J. Vece, P. Aurora, A. Moreno-Galdó); and three radiologists with 5–10 years' chILD experience (A. Calder, P. Toma, T.A. Watson). Consecutive patients were chosen and included in the study if clinically indicated DICOM format CTs were retrievable and of acceptable quality (high-resolution, ≤2 mm slice thickness) as determined by an independent radiologist (J. Jacob). Observers were given details of patient sex and age. Each scorer provided up to three choices when assigning a chILD diagnostic group or individual chILD diagnosis from a preselected list. For each choice, a measure of group/diagnostic likelihood was also assigned with confidence scores ranging from 0% to 100%: 100%=pathognomonic, 70–90%=high confidence, 40–60%=moderate confidence, 10–30%=low confidence, 0%=no confidence. The choices were based on previous histopathological work [2].

The Fleiss Kappa evaluated observer agreement for first-choice chILD groups/individual diagnoses. For chILD groups/individual diagnoses where agreement was at least fair, observer confidence was examined using linear weighted kappas [6]. Results were reanalysed according to patient age (<2 years versus >2 years, the conventional dichotomy in chILD classifications [7]) given the variable prevalence of chILD disease groups/individual diagnoses across these age ranges. Agreement was also examined in observer subgroups (senior versus junior radiologists versus senior pulmonologists). Statistical analyses were performed with R: A language and environment for statistical computing [8]. Approval for the study was obtained from the Institutional Research Committee of the Royal Brompton Hospital (Project 1157).

840 first-choice chILD group/diagnostic assignations were made by the 10 observers (table 1). chILD groups/diagnoses whose frequency was <10% of the total number of first-choice diagnoses in patients under and over 2 years of age, were grouped as “others”, in accord with previous studies [9]. Four chILD groups were analysed: airways disease (n=247), interstitial pneumonia (n=326), developmental/undefined aetiology disorders (n=147) and others (n=120). Five chILD diagnoses could be analysed in patients <2 years: infection (n=48), chronic pneumonitis of infancy (CPI; n=47), pulmonary alveolar proteinosis (PAP, n=53), developmental/undefined aetiology disorders (n=83) and others (n=119). Four chILD diagnoses could be analysed in patients >2 years: obliterative bronchiolitis (n=48), infection (n=86), fibrotic nonspecific interstitial pneumonia (fNSIP; n=47) and others (n=309).

View this table:
  • View inline
  • View popup
TABLE 1

Assignations of first-choice individual childhood interstitial lung disease (chILD) group or diagnosis in children under 2 years of age (n=35) and over 2 years of age (n=49) by 10 observers

When subanalysed according to patient age, observer agreement for first-choice chILD groups was moderate for airways disease and interstitial pneumonia in patients >2 years, but only fair in patients <2 years (table 2). There was generally less observer variation between senior radiologists than pulmonologists. In patients <2 years senior radiologists demonstrated better agreement than other observers. High confidence chILD group assignations (>70%) were more common in children >2 years and increased with observer seniority (data not shown). Encouragingly, agreement for diagnostic groups was best for infection/airways disease where conservative management without biopsy may be preferable.

View this table:
  • View inline
  • View popup
TABLE 2

Fleiss kappa values for observer agreement for first choice group assignation in the 84 study cases. Sub-analyses are shown for patients under 2 years of age (n=35) and over 2 years of age (n=49)

Observer agreement in assigning first-choice individual chILD diagnoses was moderate for obliterative bronchiolitis (in children >2 years), and fair for other diagnoses except CPI where agreement was poor. Further analyses were only performed in individual diagnoses where agreement was at least fair. Observer agreement for diagnostic likelihoods were moderate for obliterative bronchiolitis (children >2 years of age), but were at best only fair for other diagnoses, regardless of patient age (data not shown). Observer agreement for diagnostic likelihood of infection in children <2 years was poor across all observer subgroups.

We report poor agreement between even experienced thoracic radiologists for the identification of most chILD groups and individual diagnoses across ages. The lower observer agreement for individual chILD diagnoses compared with chILD diagnostic groups may reflect differing methods by which radiologists classify CT appearances. Some observers might classify according to histological pattern and distinguish features of NSIP from PAP in a child >2 years, while others might classify according to suspected aetiology and recognise both patterns as suggesting a surfactant protein disorder. Our findings stress the need for a new common uniform descriptor language for CT appearances, because the present system is not reproducible and therefore confusing.

The current classification system in chILD is based on histopathological diagnoses [2, 7], and as occurred with adult fibrosing lung diseases, it is hoped that histopathological descriptors will inform those CT features that are of importance in delineating childhood disease. Two early studies examining diagnostic accuracy using radiological–histopathological correlations in a small subset of chILD patients demonstrated that CT features could identify histopathological diagnoses with acceptable accuracy [4, 10]. However, prior to the evaluation of CT diagnostic accuracy it is essential to understand whether expert readers can coalesce on a single diagnosis with sufficient frequency that a single CT diagnosis can be compared to a single histopathological diagnosis.

Study limitations included the time frame over which cases were acquired, where CT imaging protocols and quality varied widely. However, imaging heterogeneity is an unavoidable constraint when examining real-world paediatric data and we actively sought to draw real-world conclusions on chILD observer agreement. Limiting clinical information to patient age and sex might have increased observer disagreement. However rather than examining diagnostic accuracy, our a priori study aim was to understand the limitations of CT interrogation of chILD and identify those conditions where pattern recognition alone is insufficient to make a confident diagnosis. Though the study case mix from a tertiary centre is likely to have been weighted towards more challenging presentations of disease, chILD cases are only seen with sufficient frequency to allow analysis in such centres.

Our study is the largest examination of CT imaging in chILD cases, scored by the largest number of observers, to date, who importantly were from different specialties. We demonstrate that making chILD diagnoses on CT is difficult, even amongst sub-specialists. Considering the current state of knowledge in the field, we found that agreement for chILD diagnostic groups was generally better than for individual diagnoses and was highest amongst senior radiologists. Further detailed work is needed to understand if, with studies and training, improvements in CT diagnostic agreement are possible. Additionally, the ability of the multidisciplinary team to improve diagnostic confidence by augmenting radiology with clinical, functional and haematological results, as per guideline recommendations [1, 5] requires further study.

Footnotes

  • Author contributions: JJ, CMO, ASB, TS, TAW, AC, PG-P, PT, AM-G, PA, AD, HW, TJV, SC, AA, AUW, AGN, AR, AB were involved in either the acquisition, or analysis or interpretation of data for the study. JJ, CMO and AB were also involved in the conception and design of the study. All authors revised the work for important intellectual content and gave final approval for the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Conflict of interest: J. Jacob reports personal fees from Boehringer Ingelheim (advisory board fees) and Roche, outside the submitted work.

  • Conflict of interest: C.M. Owens reports personal fees from Boehringer Ingelheim, outside the submitted work.

  • Conflict of interest: A.S. Brody reports personal fees from Vertex, outside the submitted work.

  • Conflict of interest: T. Semple reports personal fees from Vertex, outside the submitted work.

  • Conflict of interest: T.A. Watson has nothing to disclose.

  • Conflict of interest: A. Calder has nothing to disclose.

  • Conflict of interest: P. Garcia-Peña has nothing to disclose.

  • Conflict of interest: P. Toma has nothing to disclose.

  • Conflict of interest: A. Devaraj reports personal fees from Boehringer Ingelheim, Roche, and GSK, outside the submitted work.

  • Conflict of interest: H. Walton has nothing to disclose.

  • Conflict of interest: A. Moreno-Galdó reports personal fees from Abbvie, Actelion, and Novartis, outside the submitted work.

  • Conflict of interest: P. Aurora has nothing to disclose.

  • Conflict of interest: A. Rice reports personal fees from AbbVie, outside the submitted work.

  • Conflict of interest: T.J. Vece has nothing to disclose.

  • Conflict of interest: S. Cunningham reports personal fees from Boehringer Ingelheim, outside the submitted work.

  • Conflict of interest: A. Altmann has nothing to disclose.

  • Conflict of interest: A.U. Wells reports personal fees from Intermune (advisory board and speaker fees), Boehringer Inlgeheim (advisory board and speaker fees), Gilead (advisory board fees), MSD (advisory board fees), Roche (advisory board and speaker fees), Bayer (advisory board and speaker fees), and Chiesi (speaker fees), outside the submitted work.

  • Conflict of interest: A.G. Nicholson reports personal fees from Boehringer Ingelheim (advisory board fees), Roche, Medical Quantitative Image analysis, and Galapagos, outside the submitted work.

  • Conflict of interest: A. Bush has nothing to disclose.

  • Support statement: Joseph Jacob was supported by Wellcome Trust Clinical Research Career Development Fellowship 209553/Z/17/Z. Andrew Bush is an Emeritus NIHR Senior Investigator and is supported by chILD-EU (FP7, No: 305653) and the European Cooperation in Science and Technology COST A16125. Andre Altmann holds an MRC eMedLab Medical Bioinformatics Career Development Fellowship. This work was supported by the Medical Research Council (grant number MR/L016311/1). Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received April 20, 2019.
  • Accepted June 6, 2019.
  • Copyright ©ERS 2019
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Bush A,
    2. Cunningham S,
    3. de Blic J, et al.
    European protocols for the diagnosis and initial treatment of interstitial lung disease in children. Thorax 2015; 70: 1078–1084.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Rice A,
    2. Tran-Dang M-A,
    3. Bush A, et al.
    Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology 2013; 63: 743–755.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Fan LL,
    2. Dishop MK,
    3. Galambos C, et al.
    Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc 2015; 12: 1498–1505.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Copley SJ,
    2. Coren M,
    3. Nicholson AG, et al.
    Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR 2000; 174: 549–554.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kurland G,
    2. Deterding RR,
    3. Hagood JS, et al.
    An Official American Thoracic Society Clinical Practice Guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013; 188: 376–394.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Walsh SL,
    2. Calandriello L,
    3. Sverzellati N, et al.
    Hansell DM, null n. Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax 2016; 71: 45–51.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Deutsch GH,
    2. Young LR,
    3. Deterding RR, et al.
    Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176: 1120–1128.
    OpenUrlCrossRefPubMed
  8. ↵
    R Core Team. R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2016.
    1. Aziz ZA,
    2. Wells AU,
    3. Hansell DM, et al.
    HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Lynch DA,
    2. Hay T,
    3. Newell JD, Jr.., et al.
    Pediatric diffuse lung disease: diagnosis and classification using high-resolution CT. AJR 1999; 173: 713–718.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Vol 5 Issue 3 Table of Contents
ERJ Open Research: 5 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease
Joseph Jacob, Catherine M. Owens, Alan S. Brody, Thomas Semple, Tom A. Watson, Alistair Calder, Pilar Garcia-Peña, Paolo Toma, Anand Devaraj, Henry Walton, Antonio Moreno-Galdó, Paul Aurora, Alexandra Rice, Timothy J. Vece, Steve Cunningham, Andre Altmann, Athol U. Wells, Andrew G. Nicholson, Andrew Bush
ERJ Open Research Jul 2019, 5 (3) 00100-2019; DOI: 10.1183/23120541.00100-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease
Joseph Jacob, Catherine M. Owens, Alan S. Brody, Thomas Semple, Tom A. Watson, Alistair Calder, Pilar Garcia-Peña, Paolo Toma, Anand Devaraj, Henry Walton, Antonio Moreno-Galdó, Paul Aurora, Alexandra Rice, Timothy J. Vece, Steve Cunningham, Andre Altmann, Athol U. Wells, Andrew G. Nicholson, Andrew Bush
ERJ Open Research Jul 2019, 5 (3) 00100-2019; DOI: 10.1183/23120541.00100-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Lung imaging
  • Paediatric pulmonology
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • rs2070600 SNP regulates AGER splicing and sputum sRAGE
  • Procoagulant microparticles and COVID-19
  • Cancer referral and interventional pulmonology during COVID-19
Show more Original research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society